Effectiveness of and Satisfaction With a Pharmacist-managed Travel Medicine Clinic

Overview

This study will evaluate the clinical effectiveness of, and patient satisfaction with, pre-travel consultations provided by a pharmacist with specialty training in travel medicine and the authorization to prescribe medications and administer vaccinations.

Full Title of Study: “Determining the Clinical Effectiveness and Patient Satisfaction of a Pharmacist-managed Travel Medicine Clinic Under an Expanded Scope of Practice”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: April 2017

Detailed Description

The study will be conducted at the Travel Health Network, a full-service travel medicine clinic located in St. Albert, Alberta. Care will be provided by a pharmacist with a specialized practice in travel medicine, authorization to prescribe vaccines and prescription drugs, and authorization to administer vaccines by injection.

The study will be a prospective mixed-methods cohort study, describing patients receiving care from a pharmacist-managed travel medicine clinic and their travel health needs, and evaluating their adherence to recommended vaccines and oral therapies, satisfaction with the care provided, and their health status and management of health issues arising while travelling. Chart reviews will elicit descriptive quantitative data related to patients' travel medicine needs and adherence to recommended vaccinations and oral pharmacotherapy, followed by surveys containing open-ended qualitative questions to elicit overall patient satisfaction and the management of any health issues encountered during travel. Due to the nature of the study involving patients presenting to the clinic for a consultation, neither a control group nor blinding is possible.

A convenience sample of 100 subjects will be enrolled.

Interventions

  • Other: Pharmacist-provided travel care
    • Subjects will receive a pre-travel consultation from a pharmacist with specialty training in travel medicine, and with authorization to prescribe medications and vaccines and administer injections

Arms, Groups and Cohorts

  • Pharmacist-provided travel care

Clinical Trial Outcome Measures

Primary Measures

  • The proportion of recommended pre-travel vaccinations administered before departure according to chart review
    • Time Frame: Up to 7 months.
    • From date of pre-travel consultation until the date of travel departure according to participant’s planned itinerary, assessed up to September 2016.
  • The proportion of recommended pre-travel oral pharmacotherapies dispensed before departure by a community pharmacy according to electronic health record
    • Time Frame: Up to 7 months.
    • From date of pre-travel consultation until the date of travel departure according to participant’s planned itinerary, assessed up to September 2016.

Secondary Measures

  • Average satisfaction (along 1-5 scale) with care provided elicited through an online survey post-travel
    • Time Frame: 1 week following return from travel according to participant’s planned itinerary
  • Frequency of reason(s) for declining any recommended vaccines or medications according to participant self-report through an online survey
    • Time Frame: 1 week following return from travel according to participant’s planned itinerary
    • Response options: didn’t feel I was at risk, cost, concern about vaccine ingredients or safety, other (specify)
  • Number of reports of any health issues over the course of travel according to participant self-report through an online survey
    • Time Frame: 1 week following return from travel according to participant’s planned itinerary
    • Response options: Traveller’s diarrhea, Altitude sickness, Malaria, Fever (Dengue, Chikungunya), Respiratory illness, Other (specify)
  • Frequency of management strategies of any health issues over the course of travel according to participant self-report through an online survey
    • Time Frame: 1 week following return from travel according to participant’s planned itinerary
    • Response options: Nothing – it went away on its own, Took a non-prescription medication I had purchased before departure, Took a non-prescription medication I purchased while travelling, Called or emailed the Travel Health Network for advice, Searched the internet for guidance on how to manage it, Saw a physician while travelling, Saw a physician upon returning home, Other (specify)

Participating in This Clinical Trial

Inclusion Criteria

  • Receiving a pre-travel consultation at the Travel Health Network clinic in St. Albert, Alberta, Canada

Exclusion Criteria

  • Travellers with an expected return date after September 1, 2016
  • Those receiving consultations as part of a group with the same itinerary (e.g., families, group vacations) will be asked to identify one member to participate in order to minimize repetition among participants.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of Waterloo
  • Collaborator
    • University of Mississippi Medical Center
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.